Tiratricol

替拉曲考

Report date: 2026/02/03 10:32:18
NME

Base Information

Drug NameTiratricol
Drug Alias NameTiratricolum替拉曲可TriiodothyroaceticEmcitateTeatrois +[11] 
ClassificationSmall molecules
Mechanisms of ActionThyroid hormone receptor beta-1 agonistsThyroid hormone receptor alpha agonists
TargetsThyroid hormone receptor betaThyroid hormone receptor alpha
Therapy Area/IndicationsAllan-Herndon-Dudley syndromeThyrotoxicosis
Global Approved IndicationsAllan-Herndon-Dudley syndromeThyrotoxicosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2025/02/12
Country/TerritoryCzechiaUnited StatesNetherlands +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesRare Thyroid Therapeutics International Ab
China Registration ClassN/A

Develop Information

Active CompaniesFujimoto Pharmaceutical CorpEgetis Therapeutics ABRare Thyroid Therapeutics International Ab
Inactive CompaniesN/A
Active IndicationsAllan-Herndon-Dudley syndromeThyrotoxicosis
Inactive IndicationsN/A

Other Information

ATC CodeD11AX08H03AA04
Related LinksWikipediaDrugBankKEGG